Scientists Discover Cancer Cells Use Vitamin B2 To Avoid Cell Death
Vitamin B2, also known as riboflavin, is widely recognized as an essential nutrient involved in skin health and energy metabolism. However, new research suggests it may also help cancer cells survive. Scientists have discovered that tumors can exploit vitamin B2 to protect themselves from ferroptosis, a specialized form of programmed cell death.
Ferroptosis occurs when oxidative damage to a cell membrane triggers controlled cellular destruction, functioning as part of the body’s natural system for removing damaged cells. Researchers from the University of Würzburg in Germany found that depriving cancer cells of vitamin B2 made them significantly more vulnerable to ferroptosis, highlighting a potential new therapeutic target in cancer treatment.
How Cancer Cells Exploit Vitamin B2
The researchers found that vitamin B2 supports the activity of ferroptosis suppressor protein 1 (FSP1), a protein known to protect cells from ferroptotic death.
Previous studies had already identified both FSP1 and another protein, GPX4, as major regulators that prevent ferroptosis. The new study clarified how riboflavin contributes to this protective pathway.
Using large-scale genetic screening techniques, the researchers identified that FSP1 depends on a gene called RFK, which converts dietary vitamin B2 into biologically active forms usable by cells.
Laboratory experiments demonstrated that the RFK pathway channels vitamin B2 into supporting FSP1 activity, thereby strengthening tumor defenses against ferroptosis.
When this vitamin B2 processing pathway was disrupted, cancer cells became substantially more vulnerable to oxidative stress and ferroptotic cell death. These findings suggest that interfering with vitamin B2 metabolism or availability may weaken an important tumor survival mechanism.
A Vitamin Mimic That Turns Protection Into Vulnerability
The researchers also investigated roseoflavin, a synthetic compound structurally similar to vitamin B2.
In cultured cancer cells, roseoflavin appeared to promote ferroptosis rather than suppress it. The compound effectively acted as a decoy, entering cells in place of riboflavin but failing to support the protective activity of FSP1.
This mechanism allowed roseoflavin to weaken tumor defenses without directly blocking vitamin B2 function in healthy cells.
Although the research remains at an early laboratory stage, the findings point toward a potentially more selective anticancer strategy. Future vitamin B2 mimics could theoretically deprive tumors of an important protective mechanism while minimizing harm to normal tissues.
The researchers suggest that therapies based on this principle could potentially enhance the effectiveness of treatments relying on ferroptosis or oxidative stress, possibly making therapy-resistant cancers more responsive to treatment.
Balancing an Essential Nutrient and Cancer Biology
Humans cannot synthesize vitamin B2 independently and must obtain it through dietary sources such as dairy products, eggs, meat, and green vegetables.
Riboflavin plays a critical role in normal metabolism and overall health, and deficiency may lead to fatigue, skin disorders, and other complications. Importantly, the study does not suggest that vitamin B2 intake is harmful or that people should reduce dietary consumption.
Instead, the findings illustrate a biological paradox: a nutrient essential for healthy cellular function may also strengthen malignant cells under certain conditions.
By supporting FSP1 activity, riboflavin may make cancer cells more resistant to therapies designed to trigger ferroptosis. Any future therapeutic approach targeting this pathway would therefore need to carefully distinguish between healthy and cancerous tissue to avoid disrupting essential metabolic processes.
The researchers emphasize that individuals should not change their diet or supplement use based on these early findings. Clinical studies will be required to determine how vitamin B2 metabolism interacts with different cancer types and treatment strategies in humans.
Potential Implications Beyond Cancer
Although ferroptosis has only attracted major scientific attention during the past decade, it has already been implicated in several diseases beyond cancer.
Oxidative stress and ferroptosis are thought to contribute to stroke, neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, and tissue damage occurring after interrupted blood flow and reperfusion.
The Würzburg research team notes that vitamin B2’s newly identified role in ferroptosis regulation may also influence research into these conditions.
If riboflavin-dependent pathways help protect some tissues while contributing to damage in others, carefully modulating these pathways could eventually provide new therapeutic opportunities. Potential applications might include reducing neuronal damage after brain injury or limiting tissue injury following organ transplantation.
Future Research Directions
Future studies will focus on understanding how vitamin B2-dependent ferroptosis pathways operate across different tissues and disease states.
Researchers emphasize that the effects of ferroptosis can be either beneficial or harmful depending on the timing, tissue type, and disease context. Understanding when ferroptosis should be promoted or inhibited will therefore be essential for future therapeutic development.
The study, published in Nature Cell Biology, provides new insight into the complex relationship between nutrition, metabolism, and programmed cell death in human disease.
As understanding of riboflavin’s dual role continues to grow, these findings may eventually contribute to more precise, metabolism-based therapies for cancer and other disorders.
